SH2B1 gene defends against obesity via the paraventricular hypothalamus

FHS
July 15, 2024
7:38 pm

Obesity is a complicated condition, caused by a combination of genetics, the food environment, behavior, and other factors.

WuXi and BIO’s grip-and-grin

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in

April 18, 2024

Pα+ Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine; MindBio’s Microdosing Readout; Biomind’s 5-MeO-DMT Study; and more… – Psychedelic Alpha

Featured content in this Issue: Fluence and UPRA Team Up to Bring Psychedelic Therapy Training to Ukraine MindBio’s Small Open Label Microdosing Study Shows Promise

March 6, 2024

SCHOTT Pharma shares to be offered within price range of EUR 24.50 to EUR 28.50 per share – Biotech Investments

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): IPO SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma shares to be offered within price

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.